Skip to main content
. Author manuscript; available in PMC: 2019 Feb 15.
Published in final edited form as: Cornea. 2018 Jun;37(6):755–759. doi: 10.1097/ICO.0000000000001592

TABLE 2.

Clinical Features of Patients With Postoperative Toxic Keratitis

Case Sex/Age (yrs) Underlying
Disease
History of HSK Type of Surgery Cornea Before
Cataract Operation
Time Between Surgery
and Presentation (d)
1 Female/66 None No history Phaco + PCL Clear 5
2 Female/71 None No history Phaco + PCL Clear 5
3 Female/55 None No history Phaco + PCL + PPV Clear 7
4 Female/61 DM No history Phaco + PCL + PPV Clear 2
Case Perioperative
Medication
Initial Diagnosis Initial
Clinical Manifestation
Incision
Location
Final
Diagnosis
Medication After
Diagnosis
HSV-1
PCR
1 Topical steroids and antibiotics Toxic keratitis Diffuse SPEs Superior Toxic keratitis Lubrication Negative
2 Topical steroids and antibiotics Toxic keratitis Diffuse SPEs Temporal Toxic keratitis Lubrication Negative
3 Topical steroids and antibiotics Toxic keratitis Diffuse SPEs Temporal Toxic keratitis Lubrication Negative
4 Topical steroids and antibiotics Toxic keratitis Diffuse SPEs Superior Toxic keratitis Lubrication Negative

PE, superficial punctate erosion; Phaco + PCL, phacoemulsification and posterior chamber lens insertion; Phaco +PCL + PPV, phacoemulsification and posterior chamber lens insertion and pars plana vitrectomy.